{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T09:53:18Z","timestamp":1791366798009,"version":"4.3.1"},"reference-count":78,"publisher":"European Respiratory Society (ERS)","issue":"182","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir Rev"],"accepted":{"date-parts":[[2026,8,6]]},"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:p>Drug overdose remains an urgent public health concern as it is a leading cause of fatal injury in the United States, with approximately 90% being attributed to opioid-induced respiratory depression from synthetic opioids. This statistic is primarily driven by the rise in the use of fentanyl, a potent synthetic opioid and its increased use in combination with stimulant drugs. The rise in the combined use of opioids and stimulants raises questions about pharmacological and physiological interactions, and its implication for the treatment of their addictive consequences and of overdoses. Though opioid-related fatalities are due to respiratory depression and stimulant fatalities predominantly from cardiac disruption, co-use creates interactions that remain under studied. Similarly, how medications designed to treat opioid use disorder impact respiration has been mostly neglected. Here, we review preclinical and clinical studies on the effects of opioids and stimulants on respiration, focusing on brainstem respiratory nuclei, and explore implications for advancing prevention and treatment strategies for drug-related overdose.<\/jats:p>","DOI":"10.1183\/16000617.0092-2026","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T09:20:15Z","timestamp":1791364815000},"page":"260092","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of opioids and stimulants on the respiratory system"],"prefix":"10.1183","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-2890-5205","authenticated-orcid":false,"given":"Christina","family":"Lildharrie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faith N.","family":"Veenker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kylee B.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele-Vera","family":"Yonga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Abey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene-Jack","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukru B.","family":"Demiral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora D.","family":"Volkow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"key":"2026100702200736000_35.182.260092.1","doi-asserted-by":"crossref","unstructured":"Garnett MF , Mini\u00f1o AM . NCHS Data Brief. Drug overdose deaths in the United States, 2003\u20132023. Date last updated: 19 December 2024. Date last accessed: 10 June 2025. https:\/\/stacks.cdc.gov\/view\/cdc\/170565","DOI":"10.15620\/cdc\/174639"},{"key":"2026100702200736000_35.182.260092.2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwab290"},{"key":"2026100702200736000_35.182.260092.3","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12954-024-00986-z","article-title":"Motivation and context of concurrent stimulant and opioid use among persons who use drugs in the rural United States: a multi-site qualitative inquiry","volume":"21","author":"Fredericksen","year":"2024","journal-title":"Harm Reduct J"},{"key":"2026100702200736000_35.182.260092.4","doi-asserted-by":"crossref","first-page":"108224","DOI":"10.1016\/j.drugalcdep.2020.108224","article-title":"Motivations for opioid and stimulant use among drug using black sexual minority men: a life course perspective","volume":"215","author":"Dangerfield Ii","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"2026100702200736000_35.182.260092.5","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12954-015-0088-4","article-title":"Why the FUSS (Fentanyl Urine Screen Study)? A cross-sectional survey to characterize an emerging threat to people who use drugs in British Columbia, Canada","volume":"12","author":"Amlani","year":"2015","journal-title":"Harm Reduct J"},{"key":"2026100702200736000_35.182.260092.6","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15580"},{"key":"2026100702200736000_35.182.260092.7","doi-asserted-by":"crossref","first-page":"e010273","DOI":"10.1161\/CIRCEP.121.010273","article-title":"Stimulant drugs of abuse and cardiac arrhythmias","volume":"15","author":"Dominic","year":"2022","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026100702200736000_35.182.260092.8","unstructured":"Brinkman JE , Toro F , Sharma S . Physiology, respiratory drive. In: StatPearls. Treasure Island, FL, StatPearls Publishing, 2024."},{"key":"2026100702200736000_35.182.260092.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.autneu.2012.10.010"},{"key":"2026100702200736000_35.182.260092.10","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.21491"},{"key":"2026100702200736000_35.182.260092.11","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2623-09.2009"},{"key":"2026100702200736000_35.182.260092.12","doi-asserted-by":"publisher","DOI":"10.1126\/science.1683005"},{"key":"2026100702200736000_35.182.260092.13","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.57288"},{"key":"2026100702200736000_35.182.260092.14","doi-asserted-by":"publisher","DOI":"10.1152\/jn.00808.2011"},{"key":"2026100702200736000_35.182.260092.15","doi-asserted-by":"publisher","DOI":"10.1007\/s12576-016-0475-y"},{"key":"2026100702200736000_35.182.260092.16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-34047-w"},{"key":"2026100702200736000_35.182.260092.17","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.67523"},{"key":"2026100702200736000_35.182.260092.18","doi-asserted-by":"publisher","DOI":"10.1126\/science.286.5444.1566"},{"key":"2026100702200736000_35.182.260092.19","doi-asserted-by":"crossref","first-page":"e86103","DOI":"10.7554\/eLife.86103","article-title":"Role of the postinspiratory complex in regulating swallow-breathing coordination and other laryngeal behaviors","volume":"12","author":"Huff","year":"2023","journal-title":"eLife"},{"key":"2026100702200736000_35.182.260092.20","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1002\/j.2040-4603.2012.tb00457.x","article-title":"Pontine mechanisms of respiratory control","volume":"2","author":"Dutschmann","year":"2012","journal-title":"Compr Physiol"},{"key":"2026100702200736000_35.182.260092.21","doi-asserted-by":"publisher","DOI":"10.1038\/nn1517"},{"key":"2026100702200736000_35.182.260092.22","doi-asserted-by":"publisher","DOI":"10.1016\/0149-7634(79)90014-9"},{"key":"2026100702200736000_35.182.260092.23","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182662098"},{"key":"2026100702200736000_35.182.260092.24","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/bph.17369","article-title":"Mu-opioid receptors in tachykinin-1-positive cells mediate the respiratory and antinociceptive effects of the opioid fentanyl","volume":"182","author":"Furdui","year":"2025","journal-title":"Br J Pharmacol"},{"key":"2026100702200736000_35.182.260092.25","unstructured":"Dhaliwal A , Gupta M . Physiology, opioid receptor. In: StatPearls. Treasure Island, FL, StatPearls Publishing, 2025."},{"key":"2026100702200736000_35.182.260092.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.resp.2008.02.004"},{"key":"2026100702200736000_35.182.260092.27","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/B978-0-323-91534-2.00003-5","article-title":"The pathophysiology of opioid-induced respiratory depression","volume":"188","author":"Montandon","year":"2022","journal-title":"Handb Clin Neurol"},{"key":"2026100702200736000_35.182.260092.28","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00314.2024"},{"key":"2026100702200736000_35.182.260092.29","doi-asserted-by":"publisher","DOI":"10.1113\/JP278612"},{"key":"2026100702200736000_35.182.260092.30","doi-asserted-by":"publisher","DOI":"10.1111\/bph.14860"},{"key":"2026100702200736000_35.182.260092.31","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.122.001476"},{"key":"2026100702200736000_35.182.260092.32","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1507771"},{"key":"2026100702200736000_35.182.260092.33","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3723-08.2009"},{"key":"2026100702200736000_35.182.260092.34","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(98)00104-5"},{"key":"2026100702200736000_35.182.260092.35","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S0022-3565(25)10897-5","article-title":"Nalbuphine, a mixed kappa 1 and kappa 3 analgesic in mice","volume":"262","author":"Pick","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"2026100702200736000_35.182.260092.36","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/S0022-3565(25)38639-8","article-title":"Acute effects of pentazocine, naloxone and morphine in opioid-dependent volunteers","volume":"268","author":"Lamas","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"2026100702200736000_35.182.260092.37","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/bph.15592","article-title":"Insights into the mechanisms underlying opioid use disorder and potential treatment strategies","volume":"180","author":"Cao","year":"2023","journal-title":"Br J Pharmacol"},{"key":"2026100702200736000_35.182.260092.38","doi-asserted-by":"crossref","first-page":"34494","DOI":"10.1038\/s41598-025-14606-8","article-title":"Low dose naloxone mitigates opioid tolerance and dependence and restores mesenchymal stem cell function for cell therapy in addiction","volume":"15","author":"Goki","year":"2025","journal-title":"Sci Rep"},{"key":"2026100702200736000_35.182.260092.39","doi-asserted-by":"publisher","DOI":"10.1007\/s11420-007-9069-9"},{"key":"2026100702200736000_35.182.260092.40","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aen094"},{"key":"2026100702200736000_35.182.260092.41","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.neuroimage.2017.01.005","article-title":"Opioid suppression of conditioned anticipatory brain responses to breathlessness","volume":"150","author":"Hayen","year":"2017","journal-title":"Neuroimage"},{"key":"2026100702200736000_35.182.260092.42","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1138-17.2019"},{"key":"2026100702200736000_35.182.260092.43","doi-asserted-by":"publisher","DOI":"10.1093\/cercor\/bhaf313"},{"key":"2026100702200736000_35.182.260092.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2008.09.007"},{"key":"2026100702200736000_35.182.260092.45","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.anai.2024.10.018","article-title":"Opioid use disorder's impact on asthma hospitalizations: a propensity-matched nationwide study","volume":"134","author":"Gallegos-Koyner","year":"2025","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2026100702200736000_35.182.260092.46","doi-asserted-by":"crossref","first-page":"5038","DOI":"10.1038\/s41598-020-61887-2","article-title":"Opioid drug use in emergency and adverse outcomes among patients with chronic obstructive pulmonary disease: a multicenter observational study","volume":"10","author":"Viglino","year":"2020","journal-title":"Sci Rep"},{"key":"2026100702200736000_35.182.260092.47","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/cpt.2027","article-title":"Tolerance to opioid-induced respiratory depression in chronic high-dose opioid users: a model-based comparison with opioid-naive individuals","volume":"109","author":"Algera","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"2026100702200736000_35.182.260092.48","first-page":"47","article-title":"The dopamine dilemma\u2013Part II: could stimulants cause tolerance, dependence, and paradoxical decompensation?","volume":"8","author":"Yanofski","year":"2011","journal-title":"Innov Clin Neurosci"},{"key":"2026100702200736000_35.182.260092.49","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0028-3908(79)90053-4","article-title":"The stimulatory action of d-amphetamine on the respiratory centre, and its mediation by a central alpha-adrenergic mechanism","volume":"18","author":"Mediavilla","year":"1979","journal-title":"Neuropharmacology"},{"key":"2026100702200736000_35.182.260092.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2006.10.011"},{"key":"2026100702200736000_35.182.260092.51","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-013-8376-9"},{"key":"2026100702200736000_35.182.260092.52","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1186\/s12916-024-03646-y","article-title":"Chronic disease diagnoses and health service use among people who died of illicit drug toxicity in British Columbia, Canada","volume":"22","author":"Palis","year":"2024","journal-title":"BMC Med"},{"key":"2026100702200736000_35.182.260092.53","first-page":"10020","article-title":"The interplay of heart failure and lung disease: clinical correlations, mechanisms, and therapeutic implications","volume":"1","author":"Ahmad","year":"2024","journal-title":"J Respir Biol Transl Med"},{"key":"2026100702200736000_35.182.260092.54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0303403"},{"key":"2026100702200736000_35.182.260092.55","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13011-023-00515-4","article-title":"Smoking identified as preferred mode of opioid safe supply use; investigating correlates of smoking preference through a 2021 cross-sectional study in British Columbia","volume":"18","author":"Kamal","year":"2023","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"2026100702200736000_35.182.260092.56","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2004.10.011"},{"key":"2026100702200736000_35.182.260092.57","first-page":"230","article-title":"Neurotransmission of cognition, part 3. Mechanism of action of selective NRIs: both dopamine and norepinephrine increase in prefrontal cortex","volume":"64","author":"Stahl","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"2026100702200736000_35.182.260092.58","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1001\/jamapsychiatry.2017.0135","article-title":"Association of stimulant use with dopaminergic alterations in users of cocaine, amphetamine, or methamphetamine: a systematic review and meta-analysis","volume":"74","author":"Ashok","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"2026100702200736000_35.182.260092.59","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/BF03033312","article-title":"The role of the dopamine transporter in cocaine abuse","volume":"6","author":"Izenwasser","year":"2004","journal-title":"Neurotox Res"},{"key":"2026100702200736000_35.182.260092.60","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1590\/1516-3180.2014.8470910","article-title":"Pulmonary emphysema induced by methylphenidate: experimental study","volume":"133","author":"Rapello","year":"2015","journal-title":"Sao Paulo Med J"},{"key":"2026100702200736000_35.182.260092.61","doi-asserted-by":"publisher","DOI":"10.1016\/J.DRUGALCDEP.2022.109740"},{"key":"2026100702200736000_35.182.260092.62","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(93)90317-M"},{"key":"2026100702200736000_35.182.260092.63","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1999.9479612.x"},{"key":"2026100702200736000_35.182.260092.64","doi-asserted-by":"crossref","first-page":"100122","DOI":"10.1016\/j.dadr.2022.100122","article-title":"Prescription stimulant use during long-term opioid therapy and risk for opioid use disorder","volume":"5","author":"Scherrer","year":"2022","journal-title":"Drug Alcohol Depend Rep"},{"key":"2026100702200736000_35.182.260092.65","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s11524-020-00439-5","article-title":"Racial disparities in overdose prevention among people who inject drugs","volume":"97","author":"Dayton","year":"2020","journal-title":"J Urban Health"},{"key":"2026100702200736000_35.182.260092.66","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6831e1"},{"key":"2026100702200736000_35.182.260092.67","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3109\/15563659809162577","article-title":"Opioid toxicity recurrence after an initial response to naloxone","volume":"36","author":"Watson","year":"1998","journal-title":"J Toxicol Clin Toxicol"},{"key":"2026100702200736000_35.182.260092.68","unstructured":"Singh D , Saadabadi A . Naltrexone. In: StatPearls. Treasure Island, FL, StatPearls Publishing, 2025."},{"key":"2026100702200736000_35.182.260092.69","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2009.11.006"},{"key":"2026100702200736000_35.182.260092.70","doi-asserted-by":"crossref","first-page":"e2211634","DOI":"10.1001\/jamanetworkopen.2022.11634","article-title":"Analysis of stimulant prescriptions and drug-related poisoning risk among persons receiving buprenorphine treatment for opioid use disorder","volume":"5","author":"Mintz","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2026100702200736000_35.182.260092.71","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1111\/add.16760","article-title":"Association between prescribed stimulant medications and overdose among individuals receiving opioid agonist therapy: a retrospective cohort study from British Columbia, Canada","volume":"120","author":"Young","year":"2025","journal-title":"Addiction"},{"key":"2026100702200736000_35.182.260092.72","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-022-14506-w"},{"key":"2026100702200736000_35.182.260092.73","doi-asserted-by":"crossref","first-page":"209012","DOI":"10.1016\/j.josat.2023.209012","article-title":"Stimulant use among patients in opioid treatment settings: provider perspectives","volume":"151","author":"Breland","year":"2023","journal-title":"J Subst Use Addict Treat"},{"key":"2026100702200736000_35.182.260092.74","unstructured":"US Centers for Disease Control and Prevention . Preventing opioid overdose. Date last updated: 9 June 2025. Date last accessed: 15 August 2025. www.cdc.gov\/overdose-prevention\/prevention\/"},{"key":"2026100702200736000_35.182.260092.75","doi-asserted-by":"crossref","first-page":"e22411","DOI":"10.2196\/22411","article-title":"Reasons people who use opioids do not accept or carry no-cost naloxone: qualitative interview study","volume":"4","author":"Bennett","year":"2020","journal-title":"JMIR Form Res"},{"key":"2026100702200736000_35.182.260092.76","doi-asserted-by":"crossref","first-page":"e2331264","DOI":"10.1001\/jamanetworkopen.2023.31264","article-title":"Naloxone use in novel potent opioid and fentanyl overdoses in emergency department patients","volume":"6","author":"Amaducci","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2026100702200736000_35.182.260092.77","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s40429-025-00648-5","article-title":"Overdose reversal challenges and priorities in the era of synthetic opioids: insights from the respire expert forum","volume":"12","author":"Gold","year":"2025","journal-title":"Curr Addict Rep"},{"key":"2026100702200736000_35.182.260092.78","doi-asserted-by":"crossref","first-page":"691.e3","DOI":"10.1016\/j.ajem.2019.09.014","article-title":"Treatment of acute naloxone-precipitated opioid withdrawal with buprenorphine","volume":"38","author":"Chhabra","year":"2020","journal-title":"Am J Emerg Med"}],"container-title":["European Respiratory Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/16000617.0092-2026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T09:20:31Z","timestamp":1791364831000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/16000617.0092-2026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":78,"journal-issue":{"issue":"182","published-online":{"date-parts":[[2026,10,7]]},"published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1183\/16000617.0092-2026"],"URL":"https:\/\/doi.org\/10.1183\/16000617.0092-2026","relation":{},"ISSN":["0905-9180","1600-0617"],"issn-type":[{"value":"0905-9180","type":"print"},{"value":"1600-0617","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]}}}